PLoS ONE (Jan 2023)

Lower odds of COVID-19-related mortality in hospitalised patients with type II diabetes mellitus: A single-centre study.

  • Jonathan Mina,
  • Nadia L Samaha,
  • Mohamad Fleifel,
  • Janane Nasr,
  • Tony Haykal,
  • Hani Dimassi,
  • Ranime Harb,
  • Ghida El Hout,
  • Elissar Franjieh,
  • Ahmad Mahdi,
  • Jacques Mokhbat,
  • Anna Farra,
  • Rola Husni

DOI
https://doi.org/10.1371/journal.pone.0287968
Journal volume & issue
Vol. 18, no. 11
p. e0287968

Abstract

Read online

BackgroundCOVID-19 infection in patients with type 2 diabetes mellitus (T2DM) -a chronic illness in Lebanon-is not well described.MethodsThis was a single-centre retrospective observational study of 491 patients, including 152 patients with T2DM, who were hospitalised for COVID-19 between 20 August 2020 and 21 April 2021. Data on clinical characteristics, laboratory and radiological findings and outcomes were collected from the electronic medical records. Clinical characteristics and in-hospital mortality between patients with and without T2DM infected with COVID-19 using multivariate analysis were compared.ResultsPatients with T2DM were significantly older than those without T2DM (mean age, 68.7 vs. 60.3 years). Patients with T2DM were more likely to present with a body temperature of ConclusionAmong patients hospitalised for COVID-19, those with T2DM were older, presented with milder symptoms and had more comorbidities and higher troponin T levels compared with those without T2DM. Despite the worse clinical course, the patients with T2DM had lower odds of mortality than those without T2DM.